Skip to main content
PMC home page
The Journal of Experimental Medicine logoLink to The Journal of Experimental Medicine
. 1996 Jan 1;183(1):311–316. doi: 10.1084/jem.183.1.311

Interleukin (IL)-6 gene expression in the central nervous system is necessary for fever response to lipopolysaccharide or IL-1 beta: a study on IL-6-deficient mice

PMCID: PMC2192408  PMID: 8551238

Abstract

Interleukin (IL)-6, IL-1 beta, and tumor necrosis factor alpha (TNF- alpha) are considered to act as endogenous pyrogens. Because of the complex pattern of cross-inductions between these cytokines, the relative role of the central and peripheral production of these cytokines in eliciting the fever response has not yet been clarified. The purpose of this study was to determine the role of IL-6 in the fever response by making use of mice carrying a null mutation in the IL- 6 gene. The intraperitoneal injections of lipopolysaccharide (LPS) (50 micrograms/kg) and recombinant murine (rm) IL-1 beta (10 micrograms/kg), respectively, failed to evoke fever response in IL-6- deficient mice, whereas the same doses of LPS and rmIL-1 beta caused fever response in wild-type mice. The fever response could be induced in the IL-6-deficient mice by intracerebroventricular injection of recombinant human (rh) IL-6 (500 ng/mouse), whereas intracerebroventricular injection of rmIL-1 beta (100 ng/mouse) failed to produce fever response in the IL-6-deficient mice. These results suggest that central IL-6 is a necessary component of the fever response to both endogenous (IL-1 beta) and exogenous (LPS) pyrogens in mice and that IL-6 acts downstream from both peripheral and central IL- 1 beta.

Full Text

The Full Text of this article is available as a PDF (538.5 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arcone R., Pucci P., Zappacosta F., Fontaine V., Malorni A., Marino G., Ciliberto G. Single-step purification and structural characterization of human interleukin-6 produced in Escherichia coli from a T7 RNA polymerase expression vector. Eur J Biochem. 1991 Jun 15;198(3):541–547. doi: 10.1111/j.1432-1033.1991.tb16048.x. [DOI] [PubMed] [Google Scholar]
  2. Banks W. A., Kastin A. J., Ehrensing C. A. Blood-borne interleukin-1 alpha is transported across the endothelial blood-spinal cord barrier of mice. J Physiol. 1994 Sep 1;479(Pt 2):257–264. doi: 10.1113/jphysiol.1994.sp020293. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Banks W. A., Kastin A. J., Gutierrez E. G. Penetration of interleukin-6 across the murine blood-brain barrier. Neurosci Lett. 1994 Sep 26;179(1-2):53–56. doi: 10.1016/0304-3940(94)90933-4. [DOI] [PubMed] [Google Scholar]
  4. Baumann H., Ziegler S. F., Mosley B., Morella K. K., Pajovic S., Gearing D. P. Reconstitution of the response to leukemia inhibitory factor, oncostatin M, and ciliary neurotrophic factor in hepatoma cells. J Biol Chem. 1993 Apr 25;268(12):8414–8417. [PubMed] [Google Scholar]
  5. Brakenhoff J. P., de Hon F. D., Fontaine V., ten Boekel E., Schooltink H., Rose-John S., Heinrich P. C., Content J., Aarden L. A. Development of a human interleukin-6 receptor antagonist. J Biol Chem. 1994 Jan 7;269(1):86–93. [PubMed] [Google Scholar]
  6. Cornfield L. J., Sills M. A. High affinity interleukin-6 binding sites in bovine hypothalamus. Eur J Pharmacol. 1991 Sep 4;202(1):113–115. doi: 10.1016/0014-2999(91)90263-p. [DOI] [PubMed] [Google Scholar]
  7. Dinarello C. A., Cannon J. G., Mancilla J., Bishai I., Lees J., Coceani F. Interleukin-6 as an endogenous pyrogen: induction of prostaglandin E2 in brain but not in peripheral blood mononuclear cells. Brain Res. 1991 Oct 25;562(2):199–206. doi: 10.1016/0006-8993(91)90622-3. [DOI] [PubMed] [Google Scholar]
  8. Dinarello C. A. Interleukin-1. Adv Pharmacol. 1994;25:21–51. doi: 10.1016/s1054-3589(08)60429-9. [DOI] [PubMed] [Google Scholar]
  9. Engel A., Kern W. V., Mürdter G., Kern P. Kinetics and correlation with body temperature of circulating interleukin-6, interleukin-8, tumor necrosis factor alpha and interleukin-1 beta in patients with fever and neutropenia. Infection. 1994 May-Jun;22(3):160–164. doi: 10.1007/BF01716695. [DOI] [PubMed] [Google Scholar]
  10. Fattori E., Cappelletti M., Costa P., Sellitto C., Cantoni L., Carelli M., Faggioni R., Fantuzzi G., Ghezzi P., Poli V. Defective inflammatory response in interleukin 6-deficient mice. J Exp Med. 1994 Oct 1;180(4):1243–1250. doi: 10.1084/jem.180.4.1243. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Gadient R. A., Otten U. Differential expression of interleukin-6 (IL-6) and interleukin-6 receptor (IL-6R) mRNAs in rat hypothalamus. Neurosci Lett. 1993 Apr 16;153(1):13–16. doi: 10.1016/0304-3940(93)90065-s. [DOI] [PubMed] [Google Scholar]
  12. Gatti S., Bartfai T. Induction of tumor necrosis factor-alpha mRNA in the brain after peripheral endotoxin treatment: comparison with interleukin-1 family and interleukin-6. Brain Res. 1993 Oct 8;624(1-2):291–294. doi: 10.1016/0006-8993(93)90090-a. [DOI] [PubMed] [Google Scholar]
  13. HALEY T. J., MCCORMICK W. G. Pharmacological effects produced by intracerebral injection of drugs in the conscious mouse. Br J Pharmacol Chemother. 1957 Mar;12(1):12–15. doi: 10.1111/j.1476-5381.1957.tb01354.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Isshiki H., Akira S., Tanabe O., Nakajima T., Shimamoto T., Hirano T., Kishimoto T. Constitutive and interleukin-1 (IL-1)-inducible factors interact with the IL-1-responsive element in the IL-6 gene. Mol Cell Biol. 1990 Jun;10(6):2757–2764. doi: 10.1128/mcb.10.6.2757. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Klir J. J., Roth J., Szelényi Z., McClellan J. L., Kluger M. J. Role of hypothalamic interleukin-6 and tumor necrosis factor-alpha in LPS fever in rat. Am J Physiol. 1993 Sep;265(3 Pt 2):R512–R517. doi: 10.1152/ajpregu.1993.265.3.R512. [DOI] [PubMed] [Google Scholar]
  16. Kluger M. J. Fever: role of pyrogens and cryogens. Physiol Rev. 1991 Jan;71(1):93–127. doi: 10.1152/physrev.1991.71.1.93. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Kopf M., Baumann H., Freer G., Freudenberg M., Lamers M., Kishimoto T., Zinkernagel R., Bluethmann H., Köhler G. Impaired immune and acute-phase responses in interleukin-6-deficient mice. Nature. 1994 Mar 24;368(6469):339–342. doi: 10.1038/368339a0. [DOI] [PubMed] [Google Scholar]
  18. Kozak W., Conn C. A., Kluger M. J. Lipopolysaccharide induces fever and depresses locomotor activity in unrestrained mice. Am J Physiol. 1994 Jan;266(1 Pt 2):R125–R135. doi: 10.1152/ajpregu.1994.266.1.R125. [DOI] [PubMed] [Google Scholar]
  19. LeMay L. G., Otterness I. G., Vander A. J., Kluger M. J. In vivo evidence that the rise in plasma IL 6 following injection of a fever-inducing dose of LPS is mediated by IL 1 beta. Cytokine. 1990 May;2(3):199–204. doi: 10.1016/1043-4666(90)90016-m. [DOI] [PubMed] [Google Scholar]
  20. LeMay L. G., Vander A. J., Kluger M. J. Role of interleukin 6 in fever in rats. Am J Physiol. 1990 Mar;258(3 Pt 2):R798–R803. doi: 10.1152/ajpregu.1990.258.3.R798. [DOI] [PubMed] [Google Scholar]
  21. Lechan R. M., Toni R., Clark B. D., Cannon J. G., Shaw A. R., Dinarello C. A., Reichlin S. Immunoreactive interleukin-1 beta localization in the rat forebrain. Brain Res. 1990 Apr 23;514(1):135–140. doi: 10.1016/0006-8993(90)90445-h. [DOI] [PubMed] [Google Scholar]
  22. Lesnikov V. A., Efremov O. M., Korneva E. A., Van Damme J., Billiau A. Fever produced by intrahypothalamic injection of interleukin-1 and interleukin-6. Cytokine. 1991 May;3(3):195–198. doi: 10.1016/1043-4666(91)90016-7. [DOI] [PubMed] [Google Scholar]
  23. Libert C., Takahashi N., Cauwels A., Brouckaert P., Bluethmann H., Fiers W. Response of interleukin-6-deficient mice to tumor necrosis factor-induced metabolic changes and lethality. Eur J Immunol. 1994 Sep;24(9):2237–2242. doi: 10.1002/eji.1830240945. [DOI] [PubMed] [Google Scholar]
  24. Long N. C., Otterness I., Kunkel S. L., Vander A. J., Kluger M. J. Roles of interleukin 1 beta and tumor necrosis factor in lipopolysaccharide fever in rats. Am J Physiol. 1990 Oct;259(4 Pt 2):R724–R728. doi: 10.1152/ajpregu.1990.259.4.R724. [DOI] [PubMed] [Google Scholar]
  25. Mohler K. M., Torrance D. S., Smith C. A., Goodwin R. G., Stremler K. E., Fung V. P., Madani H., Widmer M. B. Soluble tumor necrosis factor (TNF) receptors are effective therapeutic agents in lethal endotoxemia and function simultaneously as both TNF carriers and TNF antagonists. J Immunol. 1993 Aug 1;151(3):1548–1561. [PubMed] [Google Scholar]
  26. Ng S. B., Tan Y. H., Guy G. R. Differential induction of the interleukin-6 gene by tumor necrosis factor and interleukin-1. J Biol Chem. 1994 Jul 22;269(29):19021–19027. [PubMed] [Google Scholar]
  27. Poli V., Balena R., Fattori E., Markatos A., Yamamoto M., Tanaka H., Ciliberto G., Rodan G. A., Costantini F. Interleukin-6 deficient mice are protected from bone loss caused by estrogen depletion. EMBO J. 1994 Mar 1;13(5):1189–1196. doi: 10.1002/j.1460-2075.1994.tb06368.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Rothwell N. J., Busbridge N. J., Lefeuvre R. A., Hardwick A. J., Gauldie J., Hopkins S. J. Interleukin-6 is a centrally acting endogenous pyrogen in the rat. Can J Physiol Pharmacol. 1991 Oct;69(10):1465–1469. doi: 10.1139/y91-219. [DOI] [PubMed] [Google Scholar]
  29. Saper C. B., Breder C. D. The neurologic basis of fever. N Engl J Med. 1994 Jun 30;330(26):1880–1886. doi: 10.1056/NEJM199406303302609. [DOI] [PubMed] [Google Scholar]
  30. Schöbitz B., de Kloet E. R., Sutanto W., Holsboer F. Cellular localization of interleukin 6 mRNA and interleukin 6 receptor mRNA in rat brain. Eur J Neurosci. 1993 Nov 1;5(11):1426–1435. doi: 10.1111/j.1460-9568.1993.tb00210.x. [DOI] [PubMed] [Google Scholar]
  31. Shalaby M. R., Waage A., Aarden L., Espevik T. Endotoxin, tumor necrosis factor-alpha and interleukin 1 induce interleukin 6 production in vivo. Clin Immunol Immunopathol. 1989 Dec;53(3):488–498. doi: 10.1016/0090-1229(89)90010-x. [DOI] [PubMed] [Google Scholar]
  32. Shapiro L., Zhang X. X., Rupp R. G., Wolff S. M., Dinarello C. A. Ciliary neurotrophic factor is an endogenous pyrogen. Proc Natl Acad Sci U S A. 1993 Sep 15;90(18):8614–8618. doi: 10.1073/pnas.90.18.8614. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Spangelo B. L., Judd A. M., MacLeod R. M., Goodman D. W., Isakson P. C. Endotoxin-induced release of interleukin-6 from rat medial basal hypothalami. Endocrinology. 1990 Oct;127(4):1779–1785. doi: 10.1210/endo-127-4-1779. [DOI] [PubMed] [Google Scholar]
  34. Taga T., Kishimoto T. Cytokine receptors and signal transduction. FASEB J. 1992 Dec;6(15):3387–3396. doi: 10.1096/fasebj.6.15.1334470. [DOI] [PubMed] [Google Scholar]
  35. Tsukada J., Saito K., Waterman W. R., Webb A. C., Auron P. E. Transcription factors NF-IL6 and CREB recognize a common essential site in the human prointerleukin 1 beta gene. Mol Cell Biol. 1994 Nov;14(11):7285–7297. doi: 10.1128/mcb.14.11.7285. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Van Snick J., Cayphas S., Vink A., Uyttenhove C., Coulie P. G., Rubira M. R., Simpson R. J. Purification and NH2-terminal amino acid sequence of a T-cell-derived lymphokine with growth factor activity for B-cell hybridomas. Proc Natl Acad Sci U S A. 1986 Dec;83(24):9679–9683. doi: 10.1073/pnas.83.24.9679. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Van Snick J. Interleukin-6: an overview. Annu Rev Immunol. 1990;8:253–278. doi: 10.1146/annurev.iy.08.040190.001345. [DOI] [PubMed] [Google Scholar]

Articles from The Journal of Experimental Medicine are provided here courtesy of The Rockefeller University Press

RESOURCES